| Montefiore Medical Center | |
| 111 East 210th Street, Bronx, New York 10467 | |
| (718) 920-4321 | |
| Name | Montefiore Medical Center |
|---|---|
| Type | Acute Care Hospital |
| Location | 111 East 210th Street, Bronx, New York |
| Ownership | Voluntary non-profit - Private |
| Emergency Services | Yes |
| Medicare ID (CCN) | 330059 |
| NPI Number | 1013222512 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 1500 Waters Pl, Bronx, NY 10461 |
| Hospital Type | Chronic Disease Hospital |
| Phone Number | 718-931-0600 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1013345065 |
| Organization Name | MONTEFIORE MOUNT VERNON HOSPITAL |
| Doing Business As | MONTEFIORE MOUNT VERNON PROFESSIONAL BILLING |
| Address | 100 Corporate Dr, Provider Information, Yonkers, NY 10701 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 914-377-4722 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1033502828 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 150 E 210th St, Bronx, NY 10467 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 718-920-4806 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1043405228 |
| Organization Name | MMC CHAM |
| Address | Mmc Cham, 3415 Bainbridge Avenue, Bronx, NY 10467 |
| Hospital Type | General Acute Care Hospital - Children |
| Phone Number | 914-377-4722 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1043543580 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 3400 Bainbridge Ave Fl 3, Bronx, NY 10467 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 718-920-4267 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1073708392 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 111 East 210th Street, Montefiore Medical Center, Bronx, NY 10467 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 914-377-4722 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1083928238 |
| Organization Name | MONTEFIORE MEDICAL CENTER-NORTH |
| Address | 600 E 233rd St, Deptt. Of Internal Medicine, 5th Floor, Bronx, NY 10466 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 610-931-3486 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1114201993 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 111 E 210th St, Bronx, NY 10467 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 718-920-4817 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1154614253 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 3331 Bainbridge Ave, Bronx, NY 10467 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 718-920-7904 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1154644607 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 4315 Webster Ave, 1j, Bronx, NY 10470 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 917-226-6195 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1174967046 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 1300 Morris Park Ave, Belfer Educational Center, Room 501, Bronx, NY 10461 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 718-430-4192 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1215010988 |
| Organization Name | BRONX STATE HOSPITAL |
| Doing Business As | BROOKLYN CHILDREN CENTER |
| Address | 1500 Waters Pl, Bronx, NY 10461 |
| Hospital Type | Psychiatric Hospital |
| Phone Number | 718-862-5409 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1235137431 |
| Organization Name | OUR LADY OF MERCY MEDICAL CENTER |
| Address | 600 E 233rd St, Bronx, NY 10466 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 718-920-9000 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1235401241 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Doing Business As | MMC AT 148TH STREET |
| Address | 334 E 148th St, Bronx, NY 10451 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 718-401-5050 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1255565925 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Doing Business As | MMC AT 3347 STEUBEN AVENUE |
| Address | 3347 Steuben Ave, Bronx, NY 10467 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 718-920-4321 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1255664991 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 111 E 210th St, Silver Zone 6th Floor, Bronx, NY 10467 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 718-920-2961 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1275763203 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 1825 Eastchester Rd # 7nw, Bronx, NY 10461 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 917-526-7062 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1275928863 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 1621 Eastchester Rd, Bronx, NY 10461 |
| Hospital Type | General Acute Care Hospital - Women |
| Phone Number | 718-405-8040 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1295163244 |
| Organization Name | MONTEFIORE NEW ROCHELLE HOSPITAL |
| Doing Business As | MONTEFIORE NEW ROCHELLE PROFESSIONAL BILLING |
| Address | 100 Corporate Dr, Provider Information, Yonkers, NY 10701 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 914-377-4722 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1336427574 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 3415 Bainbridge Ave, Bronx, NY 10467 |
| Hospital Type | General Acute Care Hospital - Children |
| Phone Number | 718-741-2400 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1407013600 |
| Organization Name | EINSTEIN DIV MONTEFIORE |
| Address | 111 E 210th St, Bronx, NY 10467 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 914-378-6163 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1417214180 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 111 East 210 Street, Bronx, NY 10467 |
| Hospital Type | Chronic Disease Hospital |
| Phone Number | 718-920-7441 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1427466283 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Doing Business As | MONTEFIORE AT ST. BARNABAS |
| Address | 4487 3rd Ave, Bronx, NY 10457 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 718-960-6381 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1447316906 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 111 E 210th St, Bronx, NY 10467 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 718-920-7924 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1477762631 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 1300 Morris Park Ave, Bronx, NY 10461 |
| Hospital Type | General Acute Care Hospital - Women |
| Phone Number | 718-430-3204 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1487984969 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 111 E 210th St, Bronx, NY 10467 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 718-920-7904 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1497146419 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 1400 Pelham Pkwy S, 218j, Bronx, NY 10461 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 718-918-4921 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1548548118 |
| Organization Name | CHILDRENS HOSPITAL AT MONTEFIORE |
| Address | 3415 Bainbridge Ave, Rosenthal 4, Bronx, NY 10467 |
| Hospital Type | Chronic Disease Hospital - Children |
| Phone Number | 718-741-2467 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1548647282 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 111 E 210th St, Bronx, NY 10467 |
| Hospital Type | General Acute Care Hospital - Women |
| Phone Number | 718-920-4093 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1629365580 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 1512 Library Ave, Bronx, NY 10465 |
| Hospital Type | Chronic Disease Hospital |
| Phone Number | 347-365-0823 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1639332877 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Doing Business As | MONTEFIORE NORTH PHYSICIANS |
| Address | 100 Corporate Dr, Cmo, Yonkers, NY 10701 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 914-377-4722 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1649514977 |
| Organization Name | MONTEFIORE CHILDREN'S HOSPITAL |
| Address | 3415 Bainbridge Ave, 9th Floor, Bronx, NY 10467 |
| Hospital Type | Chronic Disease Hospital - Children |
| Phone Number | 718-741-2100 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1649628074 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 110 East 210th St, Bronx, Bronx, NY 10467 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 718-920-4417 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1689989873 |
| Organization Name | MONTEFIORE NORTH |
| Address | 600 E 233rd St, Bronx, NY 10466 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 718-920-9108 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1710274576 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 3411 Wayne Ave Apt 11h, Bronx, NY 10467 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 310-779-2289 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1720219231 |
| Organization Name | MONTEFIORE MEDICAL CENTER NORTH DIVISION |
| Address | 600 E 233rd St, Pharmacy Department, Bronx, NY 10466 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 718-920-9631 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1750528188 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 3750 Baychester Ave, Bronx, NY 10466 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 718-654-5209 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1760646996 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 111 E 210th St, Dept. Of Medicine/endocrinology, Bronx, NY 10467 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 914-378-6163 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1790920734 |
| Organization Name | MONTEFIORE MEDICAL CENTER NORTH DIVISION |
| Address | 600 E 233rd St, Bronx, NY 10466 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 718-920-9880 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1790974897 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 111 E 210th St, Bronx, NY 10467 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 718-920-2961 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1801030481 |
| Organization Name | ALBERT EINSTEIN COLLEGE OF MEDICINE |
| Address | 111 E 210th St, Adult Outpatient Psychiatry Department, Bronx, NY 10467 |
| Hospital Type | Psychiatric Hospital |
| Phone Number | 718-920-7837 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1801147301 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 111 E 210th St, Bronx, NY 10467 |
| Hospital Type | Chronic Disease Hospital |
| Phone Number | 718-920-8840 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1841518941 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Doing Business As | MMC AT 1628 EASTCHESTER |
| Address | 1628 Eastchester Rd, Bronx, NY 10461 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 866-633-8255 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1871782979 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Doing Business As | NONE |
| Address | 1348 E 59th St, Brooklyn, NY 11234 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 718-920-2961 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1871875237 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 600 E 233rd St, Bronx, NY 10466 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 760-809-1433 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1881805430 |
| Organization Name | OUR LADY OF MERCY MEDICAL CENTER |
| Address | 600 E 233rd St, Bronx, NY 10466 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 718-920-9171 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1881893576 |
| Organization Name | LENNETTE J. BENJAMIN |
| Address | 111 E 210th St, Bronx, NY 10467 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 718-920-7375 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1881909406 |
| Organization Name | MONTEFIORE MEDICAL CENTER-NORTH |
| Address | 600 E 233rd St, Dept Of Medicine, 5th Floor, Bronx, NY 10466 |
| Hospital Type | Long Term Care Hospital |
| Phone Number | 718-920-9880 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1881972065 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 111 E 210th St, Bronx, NY 10467 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 718-920-4321 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1881998003 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 1625 Poplar St, Bronx, NY 10461 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 718-405-8550 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1942495130 |
| Organization Name | MMC EINSTEN DIVISION |
| Address | 1825 Eastchester Road, Mmc Einsten Division, Bronx, NY 10461 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 914-377-4722 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1942667340 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 3400 Bainbridge Mmc, Bronx, NY 10467 |
| Hospital Type | Chronic Disease Hospital |
| Phone Number | 718-920-4646 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1952476988 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 111 E 210th St, Bronx, NY 10467 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 718-920-4321 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1962666297 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Doing Business As | MONTEFIORE NUCLEAR MEDICINE |
| Address | 1695 Eastchester Rd # A, Bronx, NY 10461 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 718-405-8461 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1962693739 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 111 E 210th St, Bronx, NY 10467 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 718-920-6136 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1962704650 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Doing Business As | MMC 1250 WATERS PLACE |
| Address | 1250 Waters Pl, Bronx, NY 10461 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 718-920-2966 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1962895078 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 150 E 210th St, Bronx, NY 10467 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 718-920-4806 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1972821502 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Doing Business As | MMC AT 3351 STEUBEN AVENUE |
| Address | 3351 Steuben Ave, Bronx, NY 10467 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 718-920-4321 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1982860953 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Doing Business As | MONTEFIORE WAKEFIELD DIVISION |
| Address | 600 E 233rd St, Bronx, NY 10466 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 718-920-9000 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1992015937 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Address | 1500 Waters Pl, Bronx, NY 10461 |
| Hospital Type | Chronic Disease Hospital |
| Phone Number | 718-931-0600 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1992019343 |
| Organization Name | MONTEFIORE NORTH |
| Address | 600 E 233rd St, Bronx, NY 10466 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 718-920-9108 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| NPI Number | 1992072839 |
| Organization Name | MONTEFIORE MEDICAL CENTER |
| Doing Business As | NORTH DIVISION |
| Address | 600 E 233rd St, Bronx, NY 10466 |
| Hospital Type | General Acute Care Hospital - Women |
| Phone Number | 718-920-9545 |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
| Able to receive lab results electronically | Yes |
| Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
A bipartisan group of 136 members of Congress recently requested that the federal Centers for Medicare and Medicaid Services (CMS) disclose the list of homecare providers whose bids were used to calculate home medical equipment reimbursement rates under the Medicare "competitive" bidding program.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company's NDA for Omapro™ (omacetaxine mepesuccinate) for injection.
With the receipt this summer of an additional $3.75 million for a total of $7.2 million of U.S. Department of Health and Human Services funding since 2015, the Indiana Geriatrics Workforce Enhancement Program, led by Regenstrief Institute research scientist Debra Litzelman, M.A., M.D., is launching its second phase, known as GWEP 2.0.
› Verified 6 days ago
Bronx Health System Acute Care Hospital Location: 1276 Fulton Avenue, Bronx, New York 10456 Phone: (212) 588-7000 | |
Montefiore Medical Center Acute Care Hospital Location: 111 East 210th Street, Bronx, New York 10467 Phone: (718) 920-4321 | |
Lincoln Medical & Mental Health Center Acute Care Hospital Location: 234 East 149th Street, Bronx, New York 10451 Phone: (718) 579-5000 | |
Jacobi Medical Center Acute Care Hospital Location: 1400 Pelham Parkway South, Bronx, New York 10461 Phone: (718) 918-5000 | |
North Central Bronx Hospital Acute Care Hospital Location: 3424 Kossuth Avenue & 210th Street, Bronx, New York 10467 Phone: (212) 519-5000 | |
St Barnabas Hospital Acute Care Hospital Location: 4422 Third Avenue, Bronx, New York 10457 Phone: (212) 960-9000 |